Extended high frequency audiometry thresholds in healthy school children.


Journal

International journal of pediatric otorhinolaryngology
ISSN: 1872-8464
Titre abrégé: Int J Pediatr Otorhinolaryngol
Pays: Ireland
ID NLM: 8003603

Informations de publication

Date de publication:
May 2021
Historique:
received: 21 12 2020
revised: 15 02 2021
accepted: 18 03 2021
pubmed: 11 4 2021
medline: 24 6 2021
entrez: 10 4 2021
Statut: ppublish

Résumé

Extended high frequency (EHF) audiometry is the recommended method for monitoring oxotoxic hearing loss in children. This study aims to provide high quality reference audiological data for the EHF range in healthy children. Participants were 126 healthy schoolchildren between 6 and 14 years of age. All participants were term born with normal birthweight, had not suffered severe neonatal illness and had no history of middle ear disease. The averaged mean (SD) hearing threshold for the EHF 9, 10, 11.2, 12.5, 14 and 16 kHz was -0.4 (6.0) dB HL. The lowest mean hearing thresholds were observed at 14 kHz with -4.2 (8.7) dB and at 16 kHz with -6.4 (12.1) dB HL. We found significantly lower thresholds at 16 kHz for children aged 6-9 years (-8.7 dB HL) compared to age 10-14 years (-3.9 db HL), p 0.042. For both age groups the inter-subject variability increased in the highest frequencies. We found no significant differences in mean hearing thresholds between right and left ears at any frequency, and no gender differences in the EHF range. Our findings support that decreased hearing sensitivity in the EHF's may start around or even before the age of 10 years. In order to use EHF audiometry for ototoxic monitoring in children, we suggest to establish an international reference standard for hearing levels in children under the age of 18. Specific references for different age groups are needed as hearing in the EHF range appears to gradually deteriorate from an early age. NCT03253614.

Identifiants

pubmed: 33838463
pii: S0165-5876(21)00079-3
doi: 10.1016/j.ijporl.2021.110686
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03253614']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110686

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Dagny Hemmingsen (D)

Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital of North Norway, 9038 Tromsø, Norway; Paediatric Research Group, Faculty of Health Sciences, University of Tromsø-Arctic University of Norway, Postboks 6050 Langnes, 9037, Tromsø, Norway. Electronic address: dagny.e.hemmingsen@uit.no.

Niels Christian Stenklev (NC)

Ear-Nose-Throat Unit, Ishavsklinikken, Tromsø, Sjøgata 31-33, 9008, Tromsø, Norway. Electronic address: nc.stenklev@ishavsklinikken.no.

Claus Klingenberg (C)

Paediatric Research Group, Faculty of Health Sciences, University of Tromsø-Arctic University of Norway, Postboks 6050 Langnes, 9037, Tromsø, Norway; Department of Paediatrics and Adolescence Medicine, University Hospital of North Norway, 9038 Tromsø, Norway. Electronic address: claus.klingenberg@unn.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH